Jacques Bessereau

ORCID: 0000-0001-7631-9550
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Arrest and Resuscitation
  • Acute Myocardial Infarction Research
  • Coronary Interventions and Diagnostics
  • Ultrasound in Clinical Applications
  • Respiratory Support and Mechanisms
  • Venous Thromboembolism Diagnosis and Management
  • Hemodynamic Monitoring and Therapy
  • Disaster Response and Management
  • Trauma Management and Diagnosis
  • Mechanical Circulatory Support Devices
  • Travel-related health issues
  • Airway Management and Intubation Techniques
  • Heme Oxygenase-1 and Carbon Monoxide
  • Heart Rate Variability and Autonomic Control
  • Restraint-Related Deaths
  • Trauma and Emergency Care Studies
  • Maritime Navigation and Safety
  • Emergency and Acute Care Studies
  • Pleural and Pulmonary Diseases
  • Heart Failure Treatment and Management
  • Occupational Health and Performance
  • Posttraumatic Stress Disorder Research
  • Influenza Virus Research Studies
  • Injury Epidemiology and Prevention

Hôpital Nord
2015-2018

Hôpital de la Timone
2009-2015

Université d'Avignon et des Pays de Vaucluse
2015

Hôpital de la Conception
2015

Assistance Publique Hôpitaux de Marseille
2010-2013

Université de Toulon
2010

Hôpital Sainte-Marguerite
2010

Post-treatment platelet reactivity (PR) is associated with ischemic and bleeding events in patients receiving P2Y12 receptor antagonists.We aimed to study the relationship between post-treatment PR after a 60-mg loading dose (LD) of prasugrel 1-year thrombotic events.Patients were prospectively included this multicenter if they had successful percutaneous coronary intervention (PCI) for acute syndrome (ACS) received prasugrel. The index (PRI) was measured using Vasodilator-Stimulated...

10.1111/j.1538-7836.2012.04875.x article EN publisher-specific-oa Journal of Thrombosis and Haemostasis 2012-08-03

Summary Optimal platelet reactivity (PR) inhibition is critical to prevent thrombotic events in primary percutaneous coronary intervention (PCI). We aimed determine the relationship between high on-treatment (HTPR) and ST-elevation myocardial infarction (STEMI) following a 600 mg loading dose (LD) of clopidogrel. performed prospective monocentre study enrolling patients on clopidogrel undergoing PCI. The VASP index was used assess PR after LD. HTPR defined according consensus as ≥50%....

10.1160/th12-02-0125 article EN Thrombosis and Haemostasis 2012-01-01

Drowning affects more than 500,000 people worldwide and is responsible for at least 350,000 deaths each year. In France, 1235 drowning resulting in 496 were recorded the summer 2012. This retrospective study has investigated epidemiology of city Marseille (South France) between 2000 2011. We identified 449 cases unintentional drowning. The highest incidence was found among males with a median age 36 years. 5.3 victims per 10,000 inhabitants mortality rate 1.2 10,000. These accidents occurred...

10.1080/17457300.2015.1047862 article EN International Journal of Injury Control and Safety Promotion 2015-06-17

Cardiac changes induced by repeated breath‐hold diving were investigated after a fish‐catching competition. Eleven healthy subjects carried out dives at mean maximal depth of 20 ± 2.7 msw (66 9 fsw) during 5 h. One hour the competition, body mass loss was −1.7 0.5 kg. Most divers suffered from cold and although core temperature remained normal, decrease in cutaneous recorded extremities. Systolic blood pressure reduced both upper lower limbs. Heart rate unchanged, but left ventricular (LV)...

10.1111/j.1600-0838.2010.01169.x article EN Scandinavian Journal of Medicine and Science in Sports 2010-08-24

10.1016/j.admp.2013.07.099 article EN Archives des maladies professionnelles et de médecine du travail/Archives des maladies professionnelles et de l'environnement 2013-10-23

10.1007/s13341-012-0218-5 article EN Annales françaises de médecine d’urgence 2012-06-20
Coming Soon ...